Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senators Oppose Patent Reform Provisions; GSK Also Urges Revisions To Bill

This article was originally published in The Tan Sheet

Executive Summary

As patent reform legislation heads toward the Senate floor, members of the biotech and pharmaceutical industries are imploring legislators to alter key provisions. And a group of Senators is criticizing the bill's formulation for apportioning damage awards in infringement suits

You may also be interested in...



Kyl’s Patent Reform Bill Gains Acceptance From Drug And Biotech Industries

Sen. Jon Kyl plans to take up the patent reform legislation battle in the next Congress after the Senate deadlocked on Judiciary Committee Chairman Patrick Leahy's proposal

Kyl’s Patent Reform Bill Gains Acceptance From Drug And Biotech Industries

Sen. Jon Kyl plans to take up the patent reform legislation battle in the next Congress after the Senate deadlocked on Judiciary Committee Chairman Patrick Leahy's proposal

Kyl’s Patent Reform Bill Gains Acceptance From Drug And Biotech Industries

Sen. Jon Kyl plans to take up the patent reform legislation battle in the next Congress after the Senate deadlocked on Judiciary Committee Chairman Patrick Leahy's proposal

Related Content

Topics

UsernamePublicRestriction

Register

ID1132542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel